3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Neoplasms
1
Neoplasm Metastasis
1
Fibrosis
1
Colon Cancer Liver Metastasis
1
Carcinoma, Pancreatic Ductal
1
Ascites
1
Abdominal Neoplasms
1
Abdominal Injuries
1
Interventions
Gemcitabine
2
selinexor
1
ponatinib
1
neratinib
1
folfirinox
1
contrast agent BR1
1
cobimetinib
1
ceritinib
1
brigatinib
1
abemaciclib
1
Urination
1
S 1 (combination)
1
Radiotherapy
1
Radiosurgery
1
Practice Guidelines as Topic
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxaliplatin
1
Long Interspersed Nucleotide Elements
1
Laparoscopy
1
Irinotecan
1
Immunotherapy, Adoptive
1
Floxuridine
1
Etoposide
1
Endosonography
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Drug Therapy
1
Doxorubicin
1
Colchicine
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Pancreatic Ductal
×
contrast agent BR1
×
Clear all
NCT04146441
2023-01-19
PDAC
St. Olavs Hospital
Phase 2
Completed
20 enrolled